Home > Compound List > Product Information
OPC 31260 hydrochloride_Molecular_structure_CAS_138470-70-9)
Click picture or here to close

OPC 31260 hydrochloride

Catalog No. O1266 Name Sigma Aldrich
CAS Number 138470-70-9 Website http://www.sigmaaldrich.com
M. F. C27H30ClN3O2 Telephone 1-800-521-8956
M. W. 463.999 Fax
Purity ≥98% (HPLC) Email
Storage Chembase ID: 154904

SYNONYMS

IUPAC name
N-{4-[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carbonyl]phenyl}-2-methylbenzamide hydrochloride
IUPAC Traditional name
mozavaptan hydrochloride
Synonyms
Mozavaptan hydrochloride
5-(Dimethylamino)-1-[4-(2-methylbenzamido)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine hydrochloride
N-[4-(5-Dimethylamino-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)phenyl]-2-methylbenzamide hydrochloride

DATABASE IDS

CAS Number 138470-70-9
MDL Number MFCD11111965

PROPERTIES

Empirical Formula (Hill Notation) C27H29N3O2 · HCl
Purity ≥98% (HPLC)
Apperance white to tan powder
Solubility DMSO: ≥15 mg/mL
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H302
European Hazard Symbols Harmful Harmful (Xn)
MSDS Link Download
Risk Statements 22
Storage Temperature 2-8°C
German water hazard class 3

DETAILS

Description (English)
Caution
air-sensitive, hygroscopic, store with desiccant
Biochem/physiol Actions
OPC 31260 is a vasopressin V2 selective antagonist. Arginine vasopressin (AVP) plays an important part in circulatory and water homeostasis. The V2 receptor subtype is important in water retention, cardiac remodeling in congestive heart failure (CHF), and renal hemodynamic alterations, and is considered a target for polysystic kidney disease. OPC-31260 has been shown to inhibit the development of polycystic kidney disease in several animal models.
Description (简体中文)
Caution
air-sensitive, hygroscopic, store with desiccant
Biochem/physiol Actions
OPC 31260 is a vasopressin V2 selective antagonist. Arginine vasopressin (AVP) plays an important part in circulatory and water homeostasis. The V2 receptor subtype is important in water retention, cardiac remodeling in congestive heart failure (CHF), and renal hemodynamic alterations, and is considered a target for polysystic kidney disease. OPC-31260 has been shown to inhibit the development of polycystic kidney disease in several animal models.

REFERENCES